Administration of Chlorpromazine as a Treatment for COVID-19
Clinical trial NCT04354805 · UNKNOWN
Trial details
- NCT number
- NCT04354805
- Sponsor
- Cairo University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-01
- Primary completion
- 2020-10-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.